rupintrivir and other clinical-stage product candidates. Most recently, Dr. Worland founded and led eFFECTOR Therapeutics, a clinical-stage biopharmaceutical company pioneering the development of ...
Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve Worland, Ph.D. as Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback